|
|||
Dr. Mary Shannon Fracchia (Pediatrics): A 17-year-old girl was transferred to this hospital because of chest pain and hemoptysis. She had been well except for mild asthma until 4 months earlier, when pedal edema developed; testing revealed 3+ proteinuria, hematuria, and hyperlipidemia. One month later, a renal biopsy was performed at another facility, and a diagnosis of membranous glomerulonephritis was made. Testing for antibodies to hepatitis B and hepatitis C, as well as antiribonuclear protein, antitopoisomerase I, anti-Smith, anti-Ro (SS-A), anti-La (SS-B), anti–double-stranded DNA, and antinuclear antibody was negative. The levels of serum C3 and C4 complement were normal. Enalapril,
Management of Pulmonary Embolism
Thrombolytic Therapy for Pulmonary Embolism
Thrombolysis and Anticoagulation for Pulmonary Embolism
Risk Factors for Pulmonary Embolism
Anticoagulation in the Nephrotic Syndrome
Clinical Diagnosis
Pathological Discussion
Management of Membranous Glomerulonephritis
Anatomical Diagnosis
Source Information
From the Departments of Pediatrics (T.B.K., E.F.G., A.S., M.E.K.), Radiology (K.N.), and Pathology (L.D.C.), Massachusetts General Hospital; and the Departments of Pediatrics (T.B.K., E.F.G., A.S., M.E.K.), Radiology (K.N.), and Pathology (L.D.C.), Harvard Medical School.
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved. |